The rise of weight loss drugs that suppress appetite is reshaping consumer behavior, leading to decreased cravings for junk food. Predictions suggest that by 2035, 7 to 9% of Americans may use these drugs, which could lower overall calorie intake significantly. Food companies, aware of shifting consumer trends and dietary habits, must adapt to this changing landscape to remain competitive as these drugs influence consumption patterns.
Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And why it’s time to revive the siesta (17:11).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.